Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Suresh Durgam,1 Ronald P Landbloom,2 Mary Mackle,2 Xiao Wu,1 Maju Mathews,3 Henry A Nasrallah4 1Allergan Inc, Jersey City, 2Merck, Whitehouse Station, 3Forest Research Institute (now Allergan), Jersey City, NJ, 4Saint Louis University School of Medicine, St Louis, MO, USA Purpose: The primary obje...

Full description

Bibliographic Details
Main Authors: Durgam S, Landbloom RP, Mackle M, Wu X, Mathews M, Nasrallah HA
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
asenapine
schizophrenia
long-term
safety
weight
olanzapine
Online Access:https://www.dovepress.com/exploring-the-long-term-safety-of-asenapine-in-adults-with-schizophren-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/exploring-the-long-term-safety-of-asenapine-in-adults-with-schizophren-peer-reviewed-article-NDT

Similar Items